Position in CERS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$197,584
-$51,111 QoQ
Shares Held
108,563
-10.1% QoQ
Ownership
0.054%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
10 quarters on record
Voting authority
Sole 84%
Shared 0%
None 16%
Common Shares in CERS Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026Focus Partners Wealth holds $477,561,093 across 32 Medical Devices names. CERS ranks #22 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
2,520,912 | $258,822,035 | |
| 2 | GEHC |
GE HealthCare Technologies Inc.
|
894,358 | $63,660,402 | |
| 3 | SYK |
Stryker Corp
|
156,039 | $51,272,855 | |
| 4 | MDT |
Medtronic plc
|
433,122 | $37,530,021 | |
| 5 | BSX |
Boston Scientific Corp
|
411,492 | $25,821,123 | |
| 6 | ZBH |
Zimmer Biomet Holdings, Inc.
|
136,313 | $12,325,421 | |
| 7 | ITGR |
Integer Holdings Corp
|
67,386 | $5,929,968 | |
| 8 | PODD |
Insulet Corp
|
20,760 | $4,356,278 |
All Filings in CERS
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $197,584 | 108,563 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $248,695 | 120,726 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $162,626 | 102,281 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $138,641 | 98,327 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $138,225 | 99,443 | Shares | Sole | 2025-05-20 | |
| 2024-12-31 | $141,319 | 91,766 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $158,688 | 91,200 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $321,024 | 182,400 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $168,588 | 89,200 | Shares | Sole | 2024-05-16 | |
| 2023-12-31 | $196,992 | 91,200 | Shares | Sole | 2024-02-15 | |
| No filing history on record for this holder in this stock. | ||||||